Professional
Added to YB: 2025-08-08
Pitch date: 2025-06-30
PEN [bullish]
Penumbra, Inc.
+22.45%
current return
Author Info
No bio for this author
Company Info
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.
Market Cap
$11.0B
Pitch Price
$254.81
Price Target
N/A
Dividend
N/A
EV/EBITDA
47.80
P/E
67.68
EV/Sales
8.03
Sector
Health Care Equipment and Supplies
Category
growth
Baron Health Care Fund Added On Portfolio Holding: Penumbra, Inc.
PEN added to position: Medical device co w/ differentiated CAVT thrombectomy tech; only single-digit penetrated in $8B TAM (1M+ annual procedures). Strong Flash product momentum in venous setting; Storm-PE trial could show superiority vs anticoagulation alone, changing PE treatment paradigm. Thunderbolt for stroke in development.
Read full article (1 min)